Medtronic warns of unauthorized sale of dangerous products

Several laryngoscopes have surfaced on various social media platforms through unauthorized third-party sellers, prompting manufacturer Medtronic to send out a warning. The company said the scopes are defective and could pose a very serious threat to patient safety. They also said they were stolen.

The McGRATH MAC video laryngoscope is a medical device used to assist with tracheal intubation, often in critical medical situations where a patient is in crisis. However, the compromised scopes did not pass a quality check and were slated to be destroyed.

Medtronic said it is collaborating with regulatory authorities and law enforcement agencies to remove unauthorized advertisements and recover the stolen defective products. However, it’s likely too late to retrieve all of the stolen devices. Medtronic is warning providers and patients not to use the scopes for any intubation procedure, as it could lead to severe complications or death. 

The devices in question can be recognized by the presence of a serial number and packaging in one of the two designated containers. Products with item code 301-000-000 –- as well as those lacking serial numbers –- should all be considered recalled and defective

In its alert, Medtronic provided the full list of serial numbers of the dangerous laryngoscopes. Anyone with information regarding the promotion or sale of potentially stolen products are encouraged to contact Medtronic Customer Service at 800-962-9888. 

The company did not say how its products were stolen, nor how they ended up on social media marketplaces for consumer sale. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.